Parkinsons Disease (PD) Clinical Trials

10 recruiting

Frequently Asked Questions

Common questions about Parkinsons Disease (PD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Exergaming for Imrpving Upper Limb Functions in Parkinson's Disease

Parkinsons Disease (PD)
University of Health Sciences Lahore30 enrolled1 locationNCT07475741
Recruiting
Phase 1

Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Parkinsons Disease (PD)
Pravat Mandal12 enrolled1 locationNCT07064005
Recruiting
Phase 3

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Parkinsons Disease (PD)
BlueRock Therapeutics102 enrolled33 locationsNCT06944522
Recruiting
Not Applicable

Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations

Mild Cognitive Impairment (MCI)Parkinsons Disease (PD)Healthy Adult
University of Colorado, Denver80 enrolled1 locationNCT07424365
Recruiting

Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease

Parkinsons Disease (PD)
Vertero Therapeutics200 enrolled1 locationNCT07175922
Recruiting
Not Applicable

Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

Parkinsons Disease (PD)
Sanford Health64 enrolled1 locationNCT06883266
Recruiting

Biological Determinants and Neural Compensation of Dysphagia in Parkinson's Disease

Oropharyngeal DysphagiaParkinsons Disease (PD)
Heinrich-Heine University, Duesseldorf100 enrolled1 locationNCT07299448
Recruiting

Neuroimaging of Parkinson's

Parkinsons Disease (PD)
Washington University School of Medicine120 enrolled1 locationNCT07024875
Recruiting
Phase 3

Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

Parkinsons Disease (PD)
University College, London1,200 enrolled2 locationsNCT07207057
Recruiting
Phase 2

A Study of NE3107 in Early Parkinson's

Parkinsons Disease (PD)
BioVie Inc.60 enrolled4 locationsNCT06757010